Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
26.10
+0.40 (1.56%)
May 8, 2025, 11:29 AM - Market open
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $1.54 billion as of May 8, 2025. Its market cap has decreased by -38.83% in one year.
Market Cap
1.54B
Enterprise Value
518.48M
1-Year Change
-38.83%
Ranking
Category
Stock Price
$26.10
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $1.54B, an increase of 151.63%. That is a compound annual growth rate of 26.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 1.52B | -50.74% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.02B |
| Johnson & Johnson | 372.82B |
| UnitedHealth Group | 372.30B |
| AbbVie | 346.24B |
| Novo Nordisk | 307.48B |
| Abbott Laboratories | 230.49B |
| Novartis AG | 223.50B |
| AstraZeneca | 221.69B |